Method of treating inflammatory disease with cardamonin
This invention relates to a method of treating inflammatory disease characterized by the production of an undesirable level on inflammatory mediators such as nitric oxide, thromboxane B₂ , prostaglandin E₂, or hydrogen peroxide. The method comprising of administering to a patient a pharmacologycal e...
Main Authors: | Israf Ali, Daud Ahmad, Lajis, Mohd Nordin, Ahmad, Syahida, Mohamad, Habsah |
---|---|
Format: | Patent |
Published: |
2011
|
Similar Items
-
Cardamonin, inhibits pro-inflammatory mediators in activated RAW 264.7 cells and whole blood
by: Ahmad, Syahida, et al.
Published: (2006) -
Cardamonin inhibits COX and iNOS expression via inhibition of p65NF-κB nuclear translocation and Iκ-B phosphorylation in RAW 264.7 macrophage cells
by: Israf Ali, Daud Ahmad, et al.
Published: (2007) -
Activity of cardamonin on chemical model of nociception in mice
by: Chung, Pui Ping, et al.
Published: (2014) -
Antinociceptive effects of cardamonin in mice: Possible involvement of TRPV1, glutamate and opioid receptors
by: Chung, Pui Ping, et al.
Published: (2018) -
Antinociceptive Effects of Cardamonin in Mice: Possible Involvement of TRPV1, Glutamate, and Opioid Receptors
by: Chung, Pui Ping, et al.
Published: (2018)